WE ARE COMMITTED TO PROVIDING CANCER PATIENTS WITH FIRST-IN-CLASS, EFFECTIVE, AND DURABLE THERAPIES BY OVERCOMING TUMOR IMMUNE EVASION AND DRUG RESISTANCE
Our Pipeline
Multiple data read-outs expected in the next 12 months
We utilize cookies to improve our site and your experience when using it. To find more details, and to know how we obtain, store, and work with your personal data, check our Privacy Policy page.OkNoPrivacy policy
